GIVAUDAN SA/ADR (OTCMKTS:GVDNY) Receives Sell Rating from Goldman Sachs Group

Share on StockTwits

GIVAUDAN SA/ADR (OTCMKTS:GVDNY)‘s stock had its “sell” rating reissued by investment analysts at Goldman Sachs Group in a report released on Thursday, Borsen Zeitung reports.

Other equities analysts have also recently issued research reports about the company. Berenberg Bank reissued a “buy” rating on shares of GIVAUDAN SA/ADR in a report on Tuesday, January 28th. JPMorgan Chase & Co. reissued a “neutral” rating on shares of GIVAUDAN SA/ADR in a report on Friday, January 24th. Baader Bank reissued a “buy” rating on shares of GIVAUDAN SA/ADR in a report on Friday, January 24th. Sanford C. Bernstein reissued a “sell” rating on shares of GIVAUDAN SA/ADR in a report on Friday, January 31st. Finally, ValuEngine lowered GIVAUDAN SA/ADR from a “hold” rating to a “sell” rating in a research report on Tuesday, January 7th. Six investment analysts have rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold”.

Shares of GIVAUDAN SA/ADR stock opened at $67.85 on Thursday. The business has a 50 day simple moving average of $64.35 and a two-hundred day simple moving average of $58.40. GIVAUDAN SA/ADR has a 12 month low of $48.40 and a 12 month high of $67.86.

GIVAUDAN SA/ADR Company Profile

Givaudan SA, together with its subsidiaries, manufactures and sells fragrance and flavor products to the food, beverage, consumer goods, and fragrance and cosmetics industries worldwide. The company operates through two divisions, Fragrance and Flavour. The Fragrance division provides fragrance ingredients and active beauty products; fine fragrances, such as signature fragrances and line extensions; and fragrances for use in fabric and personal care, hair and skin care, household and air care, and oral care products.

Further Reading: Treasury Bonds

Analyst Recommendations for GIVAUDAN SA/ADR (OTCMKTS:GVDNY)

Receive News & Ratings for GIVAUDAN SA/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GIVAUDAN SA/ADR and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.